DPH.L - Dechra Pharmaceuticals PLC

LSE - LSE Delayed price. Currency in GBp

Dechra Pharmaceuticals PLC

24 Cheshire Avenue
Cheshire Business Park Lostock Gralam
Northwich CW9 7UA
United Kingdom
44 1606 814730

IndustryDrug Manufacturers—General
Full-time employees1,753

Key executives

NameTitlePayExercisedYear born
Mr. Ian D. PageCEO, MD & Exec. Director990kN/A1961
Dr. Anthony Gerard GriffinMD of Dechra Veterinary Products for Europe & Exec. Director576kN/A1963
Mr. Paul Nicholas Sandland MAAT, FCCACFO & Exec. DirectorN/AN/A1979
Dr. Susan LonghoferChief Scientific OfficerN/AN/A1958
Ms. Katy CloughGroup HR DirectorN/AN/AN/A
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, locomotion, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Corporate governance

Dechra Pharmaceuticals PLC’s ISS governance QualityScore as of 5 December 2019 is 5. The pillar scores are Audit: 1; Board: 6; Shareholder rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more